Drug Database
Back to search

Germany· DE-A57-26d0eda96f2c9990

Renes/Equisetum Comp.

A medicinal product containing apis mellifica ex animale toto gl dil. d31 (hab, vs. 41c), equisetum arvense ex herba ferm 35b dil. d14 (hab, vs. 35b), renes bovis gl dil. d6 (hab, vs. 41a), veratrum album e radice ferm 33c dil. d5 (hab, vs. 33c), viscum album (mali) e planta tota ferm 34i dil. d14 (hab, vs. 34i), registered in Germany by Wala Heilmittel Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRenes/Equisetum Comp.ATC—REGISTER NO.DE-A57-26d0eda96f2c99…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about apis mellifica ex animale toto gl dil. d31 (hab, vs. 41c), equisetum arvense ex herba ferm 35b dil. d14 (hab, vs. 35b), renes bovis gl dil. d6 (hab, vs. 41a), veratrum album e radice ferm 33c dil. d5 (hab, vs. 33c), viscum album (mali) e planta tota ferm 34i dil. d14 (hab, vs. 34i)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

EMA Article 57 (European Union)
Active substance
Apis Mellifica Ex Animale Toto Gl Dil. D31 (Hab, Vs. 41c), Equisetum Arvense Ex Herba Ferm 35b Dil. D14 (Hab, Vs. 35b), Renes Bovis Gl Dil. D6 (Hab, Vs. 41a), Veratrum Album E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Viscum Album (Mali) E Planta Tota Ferm 34i Dil. D14 (Hab, Vs. 34i)
Manufacturer
Wala Heilmittel Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be022d42-79ff-40da-86cd-f2504d9d9e4c
GET /v1/drugs/be022d42-79ff-40da-86cd-f2504d9d9e4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Sublingual Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Apis Mellifica Ex Animale Toto Gl Dil. D31 (Hab, Vs. 41c), Equisetum Arvense Ex Herba Ferm 35b Dil. D14 (Hab, Vs. 35b), Renes Bovis Gl Dil. D6 (Hab, Vs. 41a), Veratrum Album E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Viscum Album (Mali) E Planta Tota Ferm 34i Dil. D14 (Hab, Vs. 34i)",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about apis mellifica ex animale toto gl dil. d31 (hab, vs. 41c), equisetum arvense ex herba ferm 35b dil. d14 (hab, vs. 35b), renes bovis gl dil. d6 (hab, vs. 41a), veratrum album e radice ferm 33c dil. d5 (hab, vs. 33c), viscum album (mali) e planta tota ferm 34i dil. d14 (hab, vs. 34i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console